Heated cell therapy targets prostate cancer tumors
NCT ID NCT07240857
Summary
This early-stage study is testing a new type of CAR-T cell therapy, called ACT#001, for men with advanced prostate cancer that no longer responds to hormone therapy. The therapy involves collecting a patient's own immune cells, genetically modifying them to target a protein on prostate cancer cells, and then injecting them directly into the tumor. The main goals are to see if this local injection is safe and if it can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION RESISTANT PROSTATE CANCER (CRPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.